Quantitative EEG and Cognitive Decline in Parkinson's Disease

被引:58
|
作者
Cozac, Vitalii V. [1 ]
Gschwandtner, Ute [1 ]
Hatz, Florian [1 ]
Hardmeier, Martin [1 ]
Ruegg, Stephan [1 ]
Fuhr, Peter [1 ]
机构
[1] Univ Spital Basel, Abt Neurophysiol, Petersgraben 4, CH-4031 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
STATE FUNCTIONAL CONNECTIVITY; TEST-RETEST RELIABILITY; RESTING-STATE; ALZHEIMERS-DISEASE; FREQUENCY POWER; DEMENTIA; IMPAIRMENT; BRAIN; MEG; ELECTROENCEPHALOGRAM;
D O I
10.1155/2016/9060649
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cognitive decline is common with the progression of Parkinson's disease (PD). Different candidate biomarkers are currently studied for the risk of dementia in PD. Several studies have shown that quantitative EEG (QEEG) is a promising predictor of PD-related cognitive decline. In this paper we briefly outline the basics of QEEG analysis and analyze the recent publications addressing the predictive value of QEEG in the context of cognitive decline in PD. The MEDLINE database was searched for relevant publications from January 01, 2005, to March 02, 2015. Twenty-four studies reported QEEG findings in various cognitive states in PD. Spectral and connectivity markers of QEEG could help to discriminate between PD patients with different level of cognitive decline. QEEG variables correlate with tools for cognitive assessment over time and are associated with significant hazard ratios to predict PD-related dementia. QEEG analysis shows high test-retest reliability and avoids learning effects associated with some neuropsychological testing; it is noninvasive and relatively easy to repeat.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Association of liver fibrosis with cognitive decline in Parkinson's disease
    Zolin, Aryeh
    Zhang, Cenai
    Ooi, Hwai
    Sarva, Harini
    Kamel, Hooman
    Parikh, Neal S.
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2024, 119 : 10 - 16
  • [42] Modifiable Comorbidities Associated with Cognitive Decline in Parkinson's Disease
    Forbes, Emily
    Tropea, Thomas F.
    Mantri, Sneha
    Xie, Sharon X.
    Morley, James F.
    [J]. MOVEMENT DISORDERS CLINICAL PRACTICE, 2021, 8 (02): : 254 - 263
  • [43] Parkinson’s disease prognostic scores for progression of cognitive decline
    Galina Gramotnev
    Dmitri K. Gramotnev
    Alexandra Gramotnev
    [J]. Scientific Reports, 9
  • [44] Predictors of cognitive decline in Parkinson's disease (PD) patients
    Khizanishvili, Nino
    Beridze, Maia
    Kvirkvelia, Nana
    Khaburzania, Maka
    Kherkheulidze, Tinatin
    Kherkheulidze, Tamar
    Avazashvili, Ivane
    [J]. MOVEMENT DISORDERS, 2017, 32 : S47 - S47
  • [45] Parkinson's disease prognostic scores for progression of cognitive decline
    Gramotnev, Galina
    Gramotnev, Dmitri K.
    Gramotnev, Alexandra
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [46] Multimodal biomarkers as predictors of cognitive decline in Parkinson's disease
    Tropea, T.
    Berlyand, J.
    McBride, J.
    Doshi, J.
    Davatzikos, C.
    Shaw, L.
    Xie, S.
    Trojanowski, J.
    Weintraub, D.
    Chen-Plotkin, A.
    [J]. MOVEMENT DISORDERS, 2017, 32
  • [47] Cerebral glucose metabolism in Parkinson's disease with cognitive decline
    Maeda, T.
    Matsubara, K.
    Ibaraki, M.
    Kinoshita, T.
    Sugawara, M.
    Muraoka, R.
    Shinoda, T.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E277 - E277
  • [48] Plasma α-synuclein predicts cognitive decline in Parkinson's disease
    Lin, Chin-Hsien
    Yang, Shieh-Yueh
    Horng, Herng-Er
    Yang, Che-Chuan
    Chieh, Jen-Jie
    Chen, Hsin-Hsien
    Liu, Bing-Hsien
    Chiu, Ming-Jang
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (10): : 818 - 824
  • [49] Frontostriatal and limbic contributions to cognitive decline in Parkinson's disease
    Brown, Gregory
    Hakun, Jonathan
    Lewis, Mechelle M.
    De Jesus, Sol
    Du, Guangwei
    Eslinger, Paul J.
    Kong, Lan
    Huang, Xuemei
    [J]. JOURNAL OF NEUROIMAGING, 2023, 33 (01) : 121 - 133
  • [50] Depression in Parkinson's disease tracks cognitive decline globally
    Gary, MF
    Seignourel, P
    Crucian, GP
    Williams, LN
    Okun, MS
    Fernandez, HH
    [J]. NEUROLOGY, 2006, 66 (05) : A210 - A210